Global Trust Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History
Global Trust Asset Management, LLC
- $160 Million
- Q1 2025
A detailed history of Global Trust Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Global Trust Asset Management, LLC holds 633 shares of VRTX stock, worth $322,513. This represents 0.19% of its overall portfolio holdings.
Number of Shares
633
Previous 647
2.16%
Holding current value
$322,513
Previous $260,000
17.69%
% of portfolio
0.19%
Previous 0.1%
Shares
20 transactions
Others Institutions Holding VRTX
# of Institutions
1,804Shares Held
223MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$14.4 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.9 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.9 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$6.1 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.31 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $131B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...